|

iC9.GD2.CAR.IL-15 T Infusion Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Early 1: 1

Top Sponsors

  • UNC Lineberger Comprehensive Cancer Center1

Indications

  • Small Cell Lung Carcinoma1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

Chapel Hill, North Carolina1 trial

Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer

Lineberger Comprehensive Cancer Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.